close
TFDA ANNOUNCED THE CRITERIA FOR CLINICAL TRIAL TO STRENGTHEN DOMESTIC SOMATIC CELL-BASED THERAPEUTIC PRODUCT
 
To ensure the clinical trial of somatic cell therapy complying with the scientific standard, safety, and social ethics, as well as to protect the participants’ right, the Taiwan Food and Drug Administration, Department of Health (hereinafter TFDA) officially announced draft version of “the Criteria for Clinical Trial of Somatic Cell Therapy” (hereinafter the Draft), several months ago this year. In addition to regulating the stem cell-based treatments, the Draft also requested all related project leaders to follow the rules while preparing documents for the application of clinical trial…
 
written by Shihchang, Sun

Creative Commons License This work is licensed under a Creative Commons Attribution-ShareAlike 3.0 Taiwan License.

arrow
arrow
    文章標籤
    2011 Sep
    全站熱搜
    創作者介紹
    創作者 Alex 的頭像
    Alex

    Alex's Biolaw & Regulation Plaza

    Alex 發表在 痞客邦 留言(0) 人氣()